Otolaryngology during COVID-19: Preventive care and precautionary measures.
COVID-19
Infection control
Otolaryngology
SARS-CoV-2
Tracheotomy
Journal
American journal of otolaryngology
ISSN: 1532-818X
Titre abrégé: Am J Otolaryngol
Pays: United States
ID NLM: 8000029
Informations de publication
Date de publication:
Historique:
received:
15
04
2020
accepted:
18
04
2020
pubmed:
30
4
2020
medline:
3
7
2020
entrez:
30
4
2020
Statut:
ppublish
Résumé
Since the outbreak of novel coronavirus disease (COVID-19) in December 2019, it has spread to various regions and countries, forming a global pandemic. Reducing nosocomial infection is a new issue and challenge for all healthcare systems. Otolaryngology is a high-risk specialty as it close contact with upper respiratory tract mucous, secretions, droplets and aerosols during procedures and surgery. Therefore, infection prevention and control measures for this specialty are essential. Literatures on the epidemiology, clinical characteristics and infection control measures of COVID-19 were reviewed, practical knowledge from first-line otolaryngologists in China, the United States, and Brazil were reviewed and collated. It was recommended that otolaryngology professionals should improve screening in suspected patients with relevant nasal and pharyngeal symptoms and signs, suspend non-emergency consultations and examinations in clinics, and rearrange the working procedures in operating rooms. The guidelines of personal protective equipment for swab sampling, endoscopy and surgery were listed. Indications for tracheotomy during the pandemic should be carefully considered to avoid unnecessary airway opening and aerosol-generation; precautions during surgery to reduce the risk of exposure and infection were illustrated. This review aimed to provide recommendations for otolaryngologists to enhance personal protection against COVID-19 and reduce the risk of nosocomial infection.
Identifiants
pubmed: 32345446
pii: S0196-0709(20)30190-3
doi: 10.1016/j.amjoto.2020.102508
pmc: PMC7195080
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
102508Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no competing interests.
Références
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Chest. 2001 Dec;120(6 Suppl):375S-95S
pubmed: 11742959
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Crit Care Med. 2016 Aug;44(8):1506-14
pubmed: 27031382
Clin Infect Dis. 2020 Jul 28;71(15):778-785
pubmed: 32198501
Cochrane Database Syst Rev. 2015 Jan 12;1:CD007271
pubmed: 25581416
J Hosp Infect. 2020 Mar;104(3):246-251
pubmed: 32035997
Lancet. 2016 Nov 12;388(10058):2416-2430
pubmed: 27133972
Int J Infect Dis. 2020 Mar;92:214-217
pubmed: 32007643
JAMA Otolaryngol Head Neck Surg. 2020 Jun 1;146(6):519-520
pubmed: 32196070
JAMA. 2020 Apr 28;323(16):1610-1612
pubmed: 32129805
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Graefes Arch Clin Exp Ophthalmol. 2020 May;258(5):1049-1055
pubmed: 32124000
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
World J Otorhinolaryngol Head Neck Surg. 2020 Nov;6:S22-S25
pubmed: 32313712
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
J Evid Based Med. 2020 Feb;13(1):3-7
pubmed: 32048815
Int J Oral Sci. 2020 Mar 3;12(1):9
pubmed: 32127517
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Laryngoscope. 2014 Aug;124(8):1801-6
pubmed: 24706383
J Am Acad Dermatol. 2020 May;82(5):e177
pubmed: 32213305
Respir Care. 2013 Nov;58(11):1856-62
pubmed: 23651574
N Engl J Med. 2020 Apr 30;382(18):e41
pubmed: 32212516
Respir Care. 2016 May;61(5):615-20
pubmed: 26759420
Tuberc Respir Dis (Seoul). 2016 Oct;79(4):214-233
pubmed: 27790273
ACS Chem Neurosci. 2020 Apr 1;11(7):995-998
pubmed: 32167747
Radiology. 2020 Jun;295(3):200463
pubmed: 32077789
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
J Intensive Care. 2017 Jul 25;5:50
pubmed: 28770093
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
JAMA. 2020 Apr 21;323(15):1488-1494
pubmed: 32125362
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
JAMA. 2013 May 22;309(20):2121-9
pubmed: 23695482
Intensive Care Med. 2008 Oct;34(10):1779-87
pubmed: 18592210
Cell Host Microbe. 2020 Mar 11;27(3):325-328
pubmed: 32035028
Eur Arch Otorhinolaryngol. 2018 Mar;275(3):679-690
pubmed: 29255970
Am J Respir Crit Care Med. 2016 Oct 1;194(7):831-844
pubmed: 26974173
Can J Anaesth. 2020 May;67(5):568-576
pubmed: 32052373
Korean J Crit Care Med. 2017 May;32(2):197-204
pubmed: 31723634
PLoS One. 2012;7(4):e35797
pubmed: 22563403
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
N Engl J Med. 2020 Mar 26;382(13):1278-1280
pubmed: 32069388
Influenza Other Respir Viruses. 2013 Nov;7 Suppl 3:8-17
pubmed: 24215377
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
Intensive Care Med. 2019 Nov;45(11):1619-1621
pubmed: 31451858
Laryngoscope. 2015 Sep;125(9):2134-8
pubmed: 26152892
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204
Eur Arch Otorhinolaryngol. 2019 Jun;276(6):1823-1828
pubmed: 30941491